Healthcare News

Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand...

Origin Medical strengthens leadership ahead of launch: Sripad Devalla named CEO, Jens Thang becomes COO; adds Chris Blackley to board, 4 execs to C-suite.

Result of the payment of dividends in sharesand record of the corresponding capital increase Paris, France (June 1, 2026) – The Annual General Meeting of EssilorLuxottica has decided to grant to the...

Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante Paris, France (1er juin 2026) – L’Assemblée générale annuelle d’EssilorLuxottica a décidé de...

Risultato del pagamento del dividendo in azioni e presa d’atto dell’aumento di capitale derivante dall’esercizio dell’opzione Parigi, Francia (1 giugno 2026) – L’Assemblea Annuale degli Azionisti di...

LB2102 demonstrated a manageable safety profile and encouraging clinical activity in solid tumors among heavily pretreated patients Responses observed at higher dose levels of LB2102 with an ORR of...

NETANYA, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), today announced the expansion of its Zorronet subsidiary’s autonomous C5ISR suite to...

Ardena appoints Ariane de Ganck, PhD, as Chief Scientific Officer, reinforcing scientific focus across complex drug development programs.

NESS ZIONA, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd. (“Mapi” or the “Company”), a late-stage clinical biopharmaceutical company specializing in long-acting injectable therapies,...

Oncolytics announced data demonstrating evidence of greater anti-tumor activity with pelareorep in combination with RAS inhibitor modalities.